PRFX
HEALTHCAREPRF Technologies Ltd
$1.91-0.02 (-1.04%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PRFX Today?
No stock-specific AI insight has been generated for PRFX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.80$11.85
$1.91
Fundamentals
Market Cap$2M
P/E Ratio—
EPS$-7.47
Dividend Yield—
Dividend / Share—
ROE-0.9%
Profit Margin—
Debt / Equity—
Trading
Volume52K
Avg Volume (10D)—
Shares Outstanding845K
PRFX News
21 articles- EXCLUSIVE: PRF Technologies Advances Drop-Less Drug For Cataract Surgery PainYahoo Finance·May 1, 2026
- PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical TrialGlobeNewswire Inc.·Apr 28, 2026
- What's Going On With Pharma Company PRF Technologies On Tuesday?Benzinga·Apr 7, 2026
- PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar PlatformsYahoo Finance·Mar 27, 2026
- PRF Technologies Ltd. Announces Commercial Collaboration Agreement with Blade Ranger to Accelerate Large-Scale DeepSolar Commercial EngagementsYahoo Finance·Mar 17, 2026
- PRF Technologies’ DeepSolar Announces its First Commercial Due Diligence Engagement with EDF Power Solutions Israel, a Global Leader in Renewable EnergyYahoo Finance·Feb 18, 2026
- PRF Technologies Wins Another European Utility-Scale Solar Deployment, Expanding DeepSolar’s Installed Commercial BaseYahoo Finance·Feb 11, 2026
- PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast AccuracyYahoo Finance·Jan 20, 2026
- PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy PlatformsYahoo Finance·Jan 15, 2026
- PainReform’s LayerBio’s Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical StudiesYahoo Finance·Jan 12, 2026
- PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A MarketYahoo Finance·Jan 5, 2026
- BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability WeekYahoo Finance·Dec 30, 2025
- PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug EntitiesYahoo Finance·Dec 10, 2025
- PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular TherapyYahoo Finance·Dec 2, 2025
- PainReform’s DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset AnalysisYahoo Finance·Nov 12, 2025
- PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot ProjectsYahoo Finance·Nov 5, 2025
- PainReform Provides Business Update for the Six Months Ended June 30, 2025Yahoo Finance·Oct 1, 2025
- BC-Most Active StocksYahoo Finance·Aug 19, 2025
- PainReform/DeepSolar Accepted into NVIDIA Connect ProgramYahoo Finance·Aug 19, 2025
- PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery SystemYahoo Finance·Aug 13, 2025
- PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBioYahoo Finance·Jul 10, 2025
All 21 articles loaded
Price Data
Open$1.98
Previous Close$1.93
Day High$1.98
Day Low$1.91
52 Week High$11.85
52 Week Low$1.80
52-Week Range
$1.80$11.85
$1.91
Fundamentals
Market Cap$2M
P/E Ratio—
EPS$-7.47
Dividend Yield—
Dividend / Share—
ROE-0.9%
Profit Margin—
Debt / Equity—
Trading
Volume52K
Avg Volume (10D)—
Shares Outstanding845K
About PRF Technologies Ltd
PainReform Ltd., a pharmaceutical company specializing in clinical stages, is dedicated to the development of therapies that provide an extended period of post-surgical pain relief in Israel. The company is headquartered in Tel Aviv, Israel.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—